H2-rich water and CD34 expression in TBI ratsScientific Research


original title: Effect of hydrogen-rich water on the CD34 expression in lesion boundary brain tissue of rats with traumatic brain injury

Authors:

Ying Liu, Qin Lan, Difen Wang, Xianjun Chen, Jia Yuan, Hailing Zhang

DOI: 10.3760/cma.j.issn.2095-4352.2017.03.013

-

Abstract:

Objective: To observe the effect of hydrogen-rich water on the CD34 expression and angiogenesis in lesion boundary brain tissue of rats with traumatic brain injury (TBI).

Methods: A total of 54 adult male Sprague-Dawley (SD) rats were divided into three groups by random number table: namely sham-operated group (sham group), trauma group (TBI group), and trauma + hydrogen-rich water group (TBI+HW group), the rats in each group were subdivided into 1, 3 and 7 days subgroups according to the time points after trauma, with 6 rats in each subgroup. The TBI model was reproduced by using a modified Feency method for free fall impact, and the rats in sham group were not given brain impact after craniotomy. The rats in TBI+HW group were given intraperitoneal injection of hydrogen-rich water (5 mL/kg) after TBI model reproduction, and then once a day until being sacrificed, and the rats in sham group and TBI group were given the same amount of normal saline. The neurological severity scores (NSS) for neurologic deficits were calculated at corresponding time points, and then the rats were sacrificed for brain tissue at 3 mm around lesion boundary. After hematoxylin-eosin (HE) staining, the pathological changes in lesion boundary brain tissue were observed under light microscope. The expression of CD34+ cells was observed by immunohistochemical analysis, which markers were used to count the newborn blood capillary sprouts around the traumatic brain tissue. The protein expression of CD34 was determined by Western Blot.

Results: NSS scores at all time points in sham group were 0. NSS scores in TBI and TBI+HW groups showed a decreased tendency with time prolongation after TBI, which showed more significant in TBI+HW group, NSS scores at 3 days and 7 days were significantly lower than those of TBI group (3 day: 8.67±0.52 vs. 11.56±1.94, 7 days: 7.33±0.52 vs. 8.17±0.98, both P < 0.05). Under light microscope, the brain tissue of rats in sham group was normal. After injury, pathological changes in lesion boundary brain tissue in TBI group were characterized by obvious hemorrhagic necrosis, severe brain edema, a large number of degeneration and necrosis of nerve cells and inflammatory cell infiltration, and the pathological changes were more obvious at 3 days. The edema area in TBI+HW group was slightly smaller than that of TBI group, and the surrounding edema was slightly reduced. It was shown by immunohistochemistry that only a very small number of neoformative capillaries were found in sham group. The number of neoformative capillaries in lesion boundary brain tissue was gradually increased with time prolongation in TBI group. The number of neoformative capillaries in TBI+HW group was more significantly, which was significantly higher than that of TBI group at 3 days and 7 days after injury (cells/HP: 10.59±1.88 vs. 8.61±1.22 at 3 days, 23.20±3.16 vs. 17.01±2.64 at 7 days, both P < 0.05). It was shown by Western Blot that the expression of CD34 protein at all time points in TBI group was significantly increased as compared with that of sham group. The expression of CD34 protein at 1 day and 3 days in TBI+HW group was slightly increased as compared with that of TBI group without significant difference, but it was significantly up-regulated at 7 days after injury, which was significantly higher than that of TBI group (gray value: 1.36±0.36 vs. 0.74±0.08, P < 0.05). Conclusions: Hydrogen-rich water promote CD34+ cells home to the site of injured tissue in rats with TBI, is involved in angiogenesis, and improve clinical outcomes during brain functional recovery.

Hydrogen Therapy At Home

Beyond clinical settings, hydrogen therapy is successfully used at home — thanks to our internationally recognised devices.

At “Hydrogen Technologies” Ltd., for more than 15 years we have been developing and manufacturing “HHO Bulgaria” devices for health with hydrogen.

We are among the pioneers in the field and, unlike many of our competitors worldwide, we continue to exist and to innovate!

By choosing “HHO Bulgaria”, you support both your own health and Bulgarian innovation and manufacturing.

Meet HBS10 — Europe’s best-selling hydrogen therapy device, both in Bulgaria and worldwide.

HBS10 — Hydrogen therapy device

HBS10 → More about HBS10 TOP PRODUCT

Inhalation and water

H2 therapy device
2-in-1

Output

Hydrogen inhalation
450 ml
HHO gas per minute

Concentration

Hydrogen water
-250 mV
ORP

The device is a 2-in-1 system: use it for hydrogen inhalation or to prepare hydrogen-rich water (“hydrogen water”).

HBS10 is the only European hydrogen therapy device chromatographically tested for safety at the Bulgarian Academy of Sciences (BAS)!

In addition, the device is:

  • CE certified;
  • Tested and recommended by the renowned hydrogen therapy platform H2HUBB, USA.

Order online

H2BOOSTR Mini is our newest alternative for hydrogen therapy at home.

H2BOOSTR Mini — hydrogen water system with 100% pure molecular hydrogen

H2BOOSTR Mini → More about H2BOOSTR NEW

100% pure molecular hydrogen

100%
pure molecular
hydrogen

Ready in 30 seconds

30 seconds
to prepare

High hydrogen concentration

3.2–3.6 mg
hydrogen
per litre of water

The system saturates water with 100% pure molecular hydrogen (“hydrogen water” with maximum dissolved hydrogen).

H2BOOSTR Mini reflects Bulgarian innovation: the technology is fully engineered in Bulgaria and is the world’s only solution that prepares one litre of hydrogen water in just 30 seconds with over 3 ppm of 100% pure molecular hydrogen!

Order online

FREE PERSONAL
CONSULTATION

  • SHORT AND
    STRAIGHT TO THE POINT
  • SPECIFIC
    TO YOUR NEEDS
  • CLEAR, AND IN
    EASY-TO-UNDERSTAND LANGUAGE

Discover How Molecular Hydrogen Therapy
can help You
and Your Loved Ones.

Ask The World's First Specialized H2 Consultant,
equipped with knowledge acquired from:

2500+

Clinical Studies,
Scientific Reports and Publications
conducted Worldwide

Analyses, consultations and summaries, prepared and published on our websites by Medical Specialists:

  • Dr. Ivan Vlasov
  • Dr. Victoria Kaludova
Sylvia Panayotova - H2 Consultant

Trained by:

Sylvia
Panayotova

Hydrogen Therapy Consultant,
certified by the Molecular Hydrogen
Institute (MHI) in the U.S.